JERUSALEM--(BUSINESS WIRE)--Jan. 9, 2014--
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio
webcast at the 32nd Annual J.P. Morgan Healthcare Conference
in San Francisco, CA. Eyal Desheh, Acting President & CEO will present
on Tuesday, January 14, 2014 at 10:30 AM PT.
|
|
|
What:
|
|
|
Teva Presentation at the 32nd Annual J.P. Morgan
Healthcare Conference
|
|
|
|
|
|
|
Who:
|
|
|
Eyal Desheh, Acting President and CEO,
|
|
|
|
|
Teva Pharmaceutical Industries Ltd.
|
|
|
|
|
|
|
When:
|
|
|
Tuesday, January 14, 2014
|
|
|
|
|
|
|
Where:
|
|
|
http://jpmorgan.metameetings.com/confbook/healthcare14/directlink.php?ticker=TEVA
|
|
|
|
|
|
|
How:
|
|
|
Live over the Internet – log on to the Web at the address above
and register for
|
|
|
|
|
the event (approximately 10 minutes before). An archive of the
webcast will be
|
|
|
|
|
available on Teva’s website.
|
|
|
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic
drugs as well as innovative and specialty pharmaceuticals and active
pharmaceutical ingredients. Headquartered in Israel, Teva is the world's
leading generic drug maker, with a global product portfolio of more than
1,000 molecules and a direct presence in about 60 countries. Teva's
branded businesses focus on CNS, oncology, pain, respiratory and women's
health therapeutic areas as well as biologics. Teva currently employs
approximately 46,000 people around the world and reached $20.3 billion
in net revenues in 2012.
Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
IR Contacts:
Kevin C.
Mannix, 215-591-8912
United States
or
Tomer
Amitai, 972 (3) 926-7656
Israel
or
PR Contacts:
Iris
Beck Codner, 972 (3) 926-7246
Israel
or
Denise
Bradley, 215-591-8974
United States